Inventera Inc. (KOSDAQ: A0007J0)
Health Care · Biotechnology · KR
₩8,260.00
-0.12% today · -76.6% 1Y
Inventera Inc. (KOSDAQ: A0007J0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $45.96M.
Over the last twelve months the share price has lost 76.6%, trading between 6.09K and 60.20K.
A0007J0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.96M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩60,200.00
- 52-week low
- ₩6,090.00
- Avg volume (3M)
- —
- Shares outstanding
- 7.87M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $262.10 | -1.39% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.85 | -0.31% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $149.36 | +0.40% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $550.00 | -0.52% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $821.81 | -1.41% |
| argenx SEENXTBR: ARGX | $64.17B | €889.60 | +1.18% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $150.94 | -4.97% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.